Additionally, F10 and its metabolite FdUMP are chemically distinct from other nucleoside analogs used to treat ALL, and should not be subjected to dephosphorylation by cytosolic 5'-nucleotidase II (NT5C2). This evidence concerns the gene NT5C2 and acute lymphoblastic leukemia.